These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19949363)

  • 1. Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.
    Kimberlin DW; Shalabi M; Abzug MJ; Lang D; Jacobs RF; Storch G; Bradley JS; Wade KC; Ramilo O; Romero JR; Shelton M; Leach C; Guzman-Cottrill J; Robinson J; Abughali N; Englund J; Griffin J; Jester P; Cloud GA; Whitley RJ;
    Pediatr Infect Dis J; 2010 Mar; 29(3):195-8. PubMed ID: 19949363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
    Toovey S; Rayner C; Prinssen E; Chu T; Donner B; Thakrar B; Dutkowski R; Hoffmann G; Breidenbach A; Lindemann L; Carey E; Boak L; Gieschke R; Sacks S; Solsky J; Small I; Reddy D
    Drug Saf; 2008; 31(12):1097-114. PubMed ID: 19026027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.
    Morioka I; Nonoyama S; Tanaka-Taya K; Ihara T; Sugaya N; Ueta I; Kumagai T; Okada K; Hosoya M; Okabe N; Morishima T;
    Scand J Infect Dis; 2012 Aug; 44(8):605-9. PubMed ID: 22497443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):1-3. PubMed ID: 22233587
    [No Abstract]   [Full Text] [Related]  

  • 6. The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.
    Casscells SW; Granger E; Kress AM; Linton A
    Int J Adolesc Med Health; 2009; 21(1):79-89. PubMed ID: 19526698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Compliance and safety of oseltamivir treatment in children and infants less than one year of age].
    Tasher D; Bishop B; Stein M; Somekh E
    Harefuah; 2012 Aug; 151(8):450-4, 499. PubMed ID: 23350287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis.
    Siedler K; Skopnik H
    Pediatr Infect Dis J; 2010 Jun; 29(6):495-8. PubMed ID: 20035245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season.
    Hsieh YH; Chen KF; Gaydos CA; Rothman RE; Kelen GD
    PLoS One; 2010 Jan; 5(1):e8945. PubMed ID: 20126611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.
    Keyser LA; Karl M; Nafziger AN; Bertino JS
    Arch Intern Med; 2000 May; 160(10):1485-8. PubMed ID: 10826462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirals for influenza: strategies for use in pediatrics.
    Smith SM; Gums JG
    Paediatr Drugs; 2010 Oct; 12(5):285-99. PubMed ID: 20799758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
    Greer LG; Sheffield JS; Rogers VL; Roberts SW; McIntire DD; Wendel GD
    Obstet Gynecol; 2010 Apr; 115(4):711-716. PubMed ID: 20308829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase inhibitors in patients with underlying airways disease.
    Williamson JC; Pegram PS
    Am J Respir Med; 2002; 1(2):85-90. PubMed ID: 14720062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know.
    Mortada M; Neuenschwander P; Tekko SS
    Pediatr Nurs; 2014; 40(1):16-20. PubMed ID: 24757915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir pharmacology in young children: a commentary.
    Kamal MA
    Infect Disord Drug Targets; 2013 Feb; 13(1):2-5. PubMed ID: 23675921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.